Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 410 record(s)

Req # A-2022-000767

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107181-906, Publication of the Final Report of the Science Advisory Committee on Health Products Containing Cannabis.

Organization: Health Canada

48 page(s)
October 2022

Req # A-2022-000768

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107980-705.

Organization: Health Canada

4 page(s)
October 2022

Req # A-2022-000791

Adverse Drug Reactions (ADRs). Report numbers: 000705700, 000705752.

Organization: Health Canada

5 page(s)
October 2022

Req # A-2022-000793

Adverse Drug Reactions (ADRs). Report number: E2B_05363392.

Organization: Health Canada

34 page(s)
October 2022

Req # A-2022-000800

Adverse Drug Reactions (ADRs). Report numbers: 001000886, 001003038, 001003551, 001003831.

Organization: Health Canada

20 page(s)
October 2022

Req # A-2022-000805

Adverse Drug Reaction (ADR). Report number: 000994739.

Organization: Health Canada

7 page(s)
October 2022

Req # A-2022-000847

Adverse Drug Reaction (ADR). Report number: 001003577.

Organization: Health Canada

8 page(s)
October 2022

Req # A-2022-000926

Adverse Drug Reaction (ADR) for Asaphen E.C. Report number: 000995804. ADR for Asaphen E.C. Report number: E2B_04690490.

Organization: Health Canada

40 page(s)
October 2022

Req # A-2022-000942

Adverse Drug Reaction (ADR) for Riva-Metformin. Report number: 001008941.

Organization: Health Canada

1 page(s)
October 2022

Req # A-2021-000592

Documents in the custody of Health Canada regarding the health or religious exemption of peyote / mescaline from the Controlled Drugs and Substances Act, including, but not limited to, memoranda, position papers, internal opinions, research…

Organization: Health Canada

0 page(s)
October 2021
Date modified: